Liraglutide and semaglutide are the active ingredients in these GLP-1 medications , which treat type 2 diabetes, weight loss , or heart disease
As we age, NAD+ levels naturally decline, which may contribute to fatigue, reduced mental clarity, and slower recovery
Note: While glutathione is generally safe, everyone's body is unique
This is especially problematic when GLP-1s are already reducing gastric motility
[13] Early clinical trials showed that the peptide had to be injected about ten times a day due to its short half-life, so the company collaborated with Southern Research in the US to develop a depot formulation that would be injected under the skin, and release the peptide slowly
Kapoor carefully assess each patients unique health profile, including their response to previous treatments, to determine whether Mounjaro might be more effective for weight loss and metabolic health